Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti (Q50447674)
Jump to navigation
Jump to search
scientific article published on 31 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointesti |
scientific article published on 31 March 2017 |
Statements
Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels (English)
Stefan Sleijfer
Jaap Verweij
Axel Le Cesne
Saskia Litière
Peter Reichardt
Dusan Kotasek
Ian R Judson
Winette van der Graaf
John Zalcberg
Serge Leyvraz
Jean-Yves Blay
Sandrine Marreaud
Antonio Lopez Pousa
Elena Fumagalli
Viktor Grünwald
Antoine Italiano
Jan M Kerst
European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group